胆固醇（植物源）

简称	CAS	产品编码
Cholesterol	57-88-5	06040010300

传统的胆固醇均来源于动物，但由于现在发现很多疾病都是动物传播给人类，根据最新细胞治疗，基因治疗的指导原则，应该避免使用动物来源成分，则需要一种来源更为安全的胆固醇--植物源胆固醇。

赛诺邦格向市场供应的植物源胆固醇产品非动物来源，无基因风险，消除了人们对动物源胆固醇携带动物病毒风险的担忧，可应用于高端制剂辅料：小分子脂质体药物、核酸药物、mRNA 疫苗和蛋白质类药物的非动物源性细胞培养基等。

CDE登记号：F20220000434；DMF登记号：038440

查库存 / 立即抢购：因官网暂不支持直接下单，可点击链接跳转至商城选购，一键锁定现货
即刻跳转
胆固醇 | Cholesterol

相关文献:

1. Bian X, Guo Q, Yau LF, et al. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun. 2025;16(1):2368. Published 2025 Mar 10. doi:10.1038/s41467-025-57488-01. Peng K, Zhao X, Li H, Fu YX, Liang Y. Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control. J Exp Med. 2025;222(9):e20241454. doi:10.1084/jem.20241454
2. Ye T, Zhou J, Guo C, et al. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Rep. 2024;43(6):114269. doi:10.1016/j.celrep.2024.114269
3. Cao H, Zhang X, Cheng J, et al. A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 Infection in Mice. Vaccines (l). 2025;13(5):497. Published 2025 May 6. doi:10.3390/vaccines13050497
4. Zhang S, Wang X, Zhao T, Yang C, Huang L. Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster. Vaccines (l). 2025;13(1):68. Published 2025 Jan 13. doi:10.3390/vaccines13010068
5. Wang Z, Tian C, Zhu J, et al. Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens. J Nanobiotechnology. 2025;23(1):55. Published 2025 Jan 29. doi:10.1186/s12951-025-03156-w
6. Xiao C, Liu X, Liu P, et al. Oncogenic roles of young human de novo genes and their potential as neoantigens in cancer immunotherapy. Cell Genom. 2025;5(9):100928. doi:10.1016/j.xgen.2025.100928
7. Yu W, Chen X, Chen Q, et al. A Safe and Broad-spectrum SARS-CoV-2 mRNA Vaccine with a New Delivery System for In-situ . Virol Sin. Published online September 4, 2025. doi:10.1016/j.virs.2025.09.001
8. Wang R, Zhang Y, Du S, Li Y, Ren Y, Lin J. Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent stasis. Int J Nanomedicine. 2025;20:8951-8966. Published 2025 Jul 11. doi:10.2147/IJN.S520329
9. Li L, Luo M, Zhou L, et al. Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies. Int J Pharm. 2025;672:125282. doi:10.1016/j.ijpharm.2025.125282
10. Wu K, Xu F, Dai Y, et al. Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity. J Control Release. 2024;376:1288-1299. doi:10.1016/j.jconrel.2024.11.007
11. Wan J, Wang Z, Wang L, et al. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses. mBio. 2024;15(1):e0177523. doi:10.1128/mbio.01775-23
12. Yu, Juntao & Li, Qian & Luo, Shenggen & Wang, Xiaona & Cheng, Qiang & hu, Rongkuan. (2024). Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy. 10.1101/2024.01.11.575299.
13. Sun, Zhen & Liu, Yuxiao & Zhang, Haoyi & Ge, Ting & Pan, Yuting & Liu, Yang & Wu, Miaomiao & Shan, Tao & Wu, Qi & Zhu, Guoqiang & Chen, Kangming. (2025). Next-Generation saRNA Platforms: Systematic Screening and Engineering Enhances Superior Protein and Organ-Specific Targeting for RNA Therapeutics. 10.1101/2025.03.30.644708.
14. Liu X, Li Z, Li X, et al. A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice. Nat Commun. 2024;15(1):8932. Published 2024 Oct 16. doi:10.1038/s41467-024-53242-0
15. Chen YC, Lee YL, Lee CA, Lin TY, Hwu EE, Cheng PC. Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni. PLoS Negl Trop Dis. 2024;18(9):e0012502. Published 2024 Sep 12. doi:10.1371/journal.pntd.0012502
16. Wang L, Wan J, He W, et al. IL-7 promotes mRNA vaccine-induced long-term immunity. J Nanobiotechnology. 2024;22(1):716. Published 2024 Nov 16. doi:10.1186/s12951-024-02993-5
17. Bian X, Guo Q, Yau LF, et al. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun. 2025;16(1):2368. Published 2025 Mar 10. doi:10.1038/s41467-025-57488-0
18. Ma X, Liu S, Fan B, et al. Enhancing mRNA translation efficiency by introducing sequence optimized AU-rich elements in 3' UTR via HuR anchorage. Mol Ther Nucleic Acids. 2025;36(2):102485. Published 2025 Feb 12. doi:10.1016/j.omtn.2025.102485
19. Yufeng Zhang,Liuwei Zhang,Hui Gao, et al. Multi-functional lipid nanoformulations for enhancing the efficacy of mRNA tumor vaccines by reversing tumor immunosuppressive microenvironment[J].Nano Today, 2025, 63.DOI:10.1016/j.nantod.2025.102757.
20. Shao X, Liu L, Weng C, et al. Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines (l). 2025;13(5):448. Published 2025 Apr 24. doi:10.3390/vaccines13050448